US7654728B2
(en)
*
|
1997-10-24 |
2010-02-02 |
Revalesio Corporation |
System and method for therapeutic application of dissolved oxygen
|
US6702949B2
(en)
|
1997-10-24 |
2004-03-09 |
Microdiffusion, Inc. |
Diffuser/emulsifier for aquaculture applications
|
US20110075507A1
(en)
*
|
1997-10-24 |
2011-03-31 |
Revalesio Corporation |
Diffuser/emulsifier
|
US7402400B2
(en)
|
2001-07-03 |
2008-07-22 |
Regents Of The University Of California |
Mammalian sweet taste receptors
|
US6383778B1
(en)
|
1998-07-28 |
2002-05-07 |
The Regents Of The University Of California |
Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
|
US6875574B1
(en)
*
|
1999-01-27 |
2005-04-05 |
The Regents Of The University Of California |
Assays for sensory modulators using a sensory cell specific G-protein alpha subunit
|
GB9923146D0
(en)
*
|
1999-09-30 |
1999-12-01 |
Imperial College |
Detector array
|
TW201006846A
(en)
|
2000-03-07 |
2010-02-16 |
Senomyx Inc |
T1R taste receptor and genes encidung same
|
DK1263787T3
(da)
*
|
2000-03-14 |
2006-02-27 |
|
G-proteinkoblet receptor
|
IL152137A0
(en)
|
2000-04-07 |
2003-05-29 |
Senomyx Inc |
Tr2 taste receptors and genes encoding same
|
US7678539B2
(en)
*
|
2000-08-10 |
2010-03-16 |
Corning Incorporated |
Arrays of biological membranes and methods and use thereof
|
US6977155B2
(en)
*
|
2000-08-10 |
2005-12-20 |
Corning Incorporated |
Arrays of biological membranes and methods and use thereof
|
EP1612222B1
(en)
*
|
2000-09-22 |
2010-07-14 |
ChemCom S.A. |
Olfactory and pheromones G-protein coupled receptors
|
TW201022287A
(en)
|
2001-01-03 |
2010-06-16 |
Senomyx Inc |
T1R taste receptors and genes encoding same
|
US7309577B2
(en)
|
2001-03-07 |
2007-12-18 |
Senomyx, Inc. |
Binding assays that use the T1R1/T1R3 (umami) taste receptor to identify compounds that elicit or modulate umami taste
|
US6955887B2
(en)
*
|
2001-03-30 |
2005-10-18 |
Senomyx, Inc. |
Use of T1R hetero-oligomeric taste receptor to screen for compounds that modulate taste signaling
|
US20080244761A1
(en)
*
|
2001-03-07 |
2008-10-02 |
Senomyx, Inc. |
T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
|
US7368285B2
(en)
|
2001-03-07 |
2008-05-06 |
Senomyx, Inc. |
Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same
|
US7301009B2
(en)
|
2001-06-26 |
2007-11-27 |
Senomyx, Inc. |
Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli
|
US7763431B1
(en)
|
2001-03-07 |
2010-07-27 |
Senomyx, Inc. |
Binding assays that use the T1R2/T1R3 (sweet) taste receptor to identify compounds that elicit or modulate sweet taste
|
US7883856B2
(en)
|
2001-04-05 |
2011-02-08 |
Senomyx Inc. |
Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
|
IL158488A0
(en)
*
|
2001-04-20 |
2004-05-12 |
Sinai School Medicine |
Tir3 a novel taste receptor
|
US7803982B2
(en)
|
2001-04-20 |
2010-09-28 |
The Mount Sinai School Of Medicine Of New York University |
T1R3 transgenic animals, cells and related methods
|
DK2327985T3
(en)
|
2001-06-26 |
2016-09-05 |
Senomyx Inc |
H1 Oligomeric T1R Taste Receptors and Cell Lines Expressing the Receptors, and Their Use to Identify Taste Compounds
|
WO2003001876A2
(en)
*
|
2001-06-26 |
2003-01-09 |
Senomyx, Inc. |
T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
|
JP5001512B2
(ja)
*
|
2001-06-26 |
2012-08-15 |
セノミックス インコーポレイテッド |
T1rヘテロオリゴマー味覚受容体及び前記受容体を発現する細胞系並びに味覚化合物の特定のためのその使用
|
JP2005505262A
(ja)
|
2001-07-03 |
2005-02-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
哺乳動物の甘味およびアミノ酸のヘテロダイマー性の味覚レセプター
|
MXPA03011805A
(es)
|
2001-07-06 |
2004-07-01 |
Senomyx Inc |
Expresion del canal de compuerta de nucleotido ciclico olfatorio humano funcional en celulas hospedadoras recombinantes y uso de los mismos en ensayos basados en celulas para identificar moduladores del olfato.
|
AU2002318229B2
(en)
|
2001-07-10 |
2008-03-13 |
Senomyx, Inc. |
Use of specific T2R taste receptors to identify compounds that block bitter taste
|
AU2002326436A1
(en)
*
|
2001-07-19 |
2003-03-03 |
Icogen Corporation |
Methods for identification of activators of g protein-coulpled receptors and nucleic acids encoding those receptors
|
US7314725B2
(en)
|
2001-07-20 |
2008-01-01 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Phenylthiocarbamide (PTC) taste receptor
|
WO2003025137A2
(en)
*
|
2001-09-18 |
2003-03-27 |
Irm, Llc |
Sweet taste receptors
|
US20050208495A1
(en)
*
|
2002-09-17 |
2005-09-22 |
Joseph Richard A |
Real-time detection of nucleic acid reactions
|
AU2004258071A1
(en)
*
|
2003-06-19 |
2005-01-27 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Variants of human taste receptor genes
|
US7527944B2
(en)
|
2003-06-27 |
2009-05-05 |
Monell Chemical Senses Center |
Taste receptors of the T1R family from domestic cat
|
US7517968B2
(en)
*
|
2003-07-07 |
2009-04-14 |
Syracuse University |
Rapid and inexpensive method for the purification of proteorhodopsin
|
CN103275058B
(zh)
*
|
2003-08-06 |
2016-02-24 |
西诺米克斯公司 |
调味剂、味道调节剂、促味剂、味觉增强剂、鲜味剂或甜味剂和/或增强剂及其用途
|
US20050106571A1
(en)
|
2003-10-02 |
2005-05-19 |
The Regents Of The University Of California |
Mammalian T1R3 sweet taste receptors
|
US20060045953A1
(en)
*
|
2004-08-06 |
2006-03-02 |
Catherine Tachdjian |
Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers
|
WO2006084184A2
(en)
*
|
2005-02-04 |
2006-08-10 |
Senomyx, Inc. |
Molecules comprising linked organic moieties as flavor modifiers for comestible compositions
|
JP4734346B2
(ja)
|
2005-02-04 |
2011-07-27 |
セノミックス インコーポレイテッド |
連結ヘテロアリール部分を含む化合物、ならびに食用組成物のための新規なうまみフレーバー改変剤、味物質および味覚増強剤としての使用
|
WO2006113422A2
(en)
*
|
2005-04-13 |
2006-10-26 |
The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Services |
Human sweet and umami taste receptor variants
|
AR055329A1
(es)
*
|
2005-06-15 |
2007-08-15 |
Senomyx Inc |
Amidas bis-aromaticas y sus usos como modificadores de sabor dulce, saborizantes, y realzadores de sabor
|
JP5342878B2
(ja)
|
2005-10-20 |
2013-11-13 |
セノミクス・インコーポレーテッド |
キメラヒト甘味‐旨味および旨味‐甘味味覚受容体
|
US9101160B2
(en)
|
2005-11-23 |
2015-08-11 |
The Coca-Cola Company |
Condiments with high-potency sweetener
|
JP6095881B2
(ja)
*
|
2006-04-20 |
2017-03-15 |
ジボダン エス エー |
甘味増強に関する方法
|
US20110097741A1
(en)
*
|
2006-04-20 |
2011-04-28 |
Jay Patrick Slack |
Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays
|
EP3235811B1
(en)
|
2006-04-21 |
2018-07-25 |
Senomyx, Inc. |
Process of preparing oxalamides
|
US9019300B2
(en)
*
|
2006-08-04 |
2015-04-28 |
Apple Inc. |
Framework for graphics animation and compositing operations
|
US7777877B2
(en)
*
|
2006-10-20 |
2010-08-17 |
California Institute Of Technology |
High efficiency coupling optics for pumping and detection of fluorescence
|
US8784898B2
(en)
|
2006-10-25 |
2014-07-22 |
Revalesio Corporation |
Methods of wound care and treatment
|
US8445546B2
(en)
|
2006-10-25 |
2013-05-21 |
Revalesio Corporation |
Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
|
US8609148B2
(en)
*
|
2006-10-25 |
2013-12-17 |
Revalesio Corporation |
Methods of therapeutic treatment of eyes
|
US8784897B2
(en)
|
2006-10-25 |
2014-07-22 |
Revalesio Corporation |
Methods of therapeutic treatment of eyes
|
AU2007308840C1
(en)
|
2006-10-25 |
2014-09-25 |
Revalesio Corporation |
Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
|
AU2007308838B2
(en)
|
2006-10-25 |
2014-03-13 |
Revalesio Corporation |
Mixing device and output fluids of same
|
JP5491185B2
(ja)
*
|
2006-10-25 |
2014-05-14 |
リバルシオ コーポレイション |
傷のケアおよび処置の方法
|
US8017168B2
(en)
|
2006-11-02 |
2011-09-13 |
The Coca-Cola Company |
High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
|
EP2195656A4
(en)
|
2007-08-21 |
2011-10-19 |
Senomyx Inc |
HUMAN T2R BITTERITY RECEPTORS AND USES THEREOF
|
US20100015235A1
(en)
*
|
2008-04-28 |
2010-01-21 |
Revalesio Corporation |
Compositions and methods for treating multiple sclerosis
|
US20100303917A1
(en)
*
|
2007-10-25 |
2010-12-02 |
Revalesio Corporation |
Compositions and methods for treating cystic fibrosis
|
US20100303918A1
(en)
*
|
2007-10-25 |
2010-12-02 |
Revalesio Corporation |
Compositions and methods for treating asthma and other lung disorders
|
US20090227018A1
(en)
*
|
2007-10-25 |
2009-09-10 |
Revalesio Corporation |
Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
|
US20100009008A1
(en)
*
|
2007-10-25 |
2010-01-14 |
Revalesio Corporation |
Bacteriostatic or bacteriocidal compositions and methods
|
US20100029764A1
(en)
*
|
2007-10-25 |
2010-02-04 |
Revalesio Corporation |
Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
|
US9745567B2
(en)
*
|
2008-04-28 |
2017-08-29 |
Revalesio Corporation |
Compositions and methods for treating multiple sclerosis
|
US10125359B2
(en)
*
|
2007-10-25 |
2018-11-13 |
Revalesio Corporation |
Compositions and methods for treating inflammation
|
CA2703672A1
(en)
*
|
2007-10-25 |
2009-04-30 |
Revalesio Corporation |
Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
|
US9523090B2
(en)
|
2007-10-25 |
2016-12-20 |
Revalesio Corporation |
Compositions and methods for treating inflammation
|
CA2723215A1
(en)
*
|
2008-05-01 |
2009-11-05 |
Revalesio Corporation |
Compositions and methods for treating digestive disorders
|
CA2741336A1
(en)
*
|
2008-10-22 |
2010-04-29 |
Revalesio Corporation |
Compositions and methods for treating thymic stromal lymphopoietin (tslp)-mediated conditions
|
US20100098659A1
(en)
*
|
2008-10-22 |
2010-04-22 |
Revalesio Corporation |
Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions
|
US8815292B2
(en)
|
2009-04-27 |
2014-08-26 |
Revalesio Corporation |
Compositions and methods for treating insulin resistance and diabetes mellitus
|
CN101763735B
(zh)
*
|
2010-02-01 |
2015-02-25 |
王茜 |
可具有负系统损失时间的动态信号控制系统的控制方法
|
EP2552947A4
(en)
|
2010-03-26 |
2013-11-13 |
Dartmouth College |
VISTA REGULATORY T CELL MEDIATOR PROTEIN, VISTA BINDING ACTIVE SUBSTANCES AND USE THEREOF
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US9198929B2
(en)
|
2010-05-07 |
2015-12-01 |
Revalesio Corporation |
Compositions and methods for enhancing physiological performance and recovery time
|
EP3327035A1
(en)
|
2010-06-22 |
2018-05-30 |
Precision Biologics Inc. |
Colon and pancreas cancer specific antigens and antibodies
|
CA2808189A1
(en)
|
2010-08-12 |
2012-02-16 |
Revalesio Corporation |
Compositions and methods for treatment of taupathy
|
CA3182320A1
(en)
|
2010-09-23 |
2012-03-29 |
Precision Biologics, Inc. |
Colon and pancreas cancer peptidomimetics
|
CA2837184C
(en)
|
2011-05-25 |
2021-09-21 |
Innate Pharma, S.A. |
Anti-kir antibodies for the treatment of inflammatory and autoimmune disorders
|
EP2742350B1
(en)
|
2011-08-08 |
2019-10-30 |
The Coca-Cola Company |
Cell lines comprising endogenous taste receptors and their uses
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
CA2877533C
(en)
|
2012-06-22 |
2022-08-16 |
The Trustees Of Dartmouth College |
Novel vista-ig constructs and the use of vista-ig for treatment of autoimmune, allergic and inflammatory disorders
|
EP2892558B1
(en)
|
2012-09-07 |
2019-04-10 |
The Trustees Of Dartmouth College |
Vista modulators for diagnosis and treatment of cancer
|
AU2013370171B2
(en)
|
2012-12-28 |
2018-09-13 |
Precision Biologics, Inc. |
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
|
US9804157B1
(en)
|
2013-03-15 |
2017-10-31 |
Senomyx, Inc. |
Screening assays to identify compounds which modulate T1R associated taste modalities which eliminate false positives
|
MX2016007533A
(es)
|
2013-12-09 |
2016-12-14 |
Univ New York |
Composiciones y metodos para el suministro fagocitico de agentes anti-estafilococicos.
|
ES2920677T3
(es)
|
2013-12-24 |
2022-08-08 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-VISTA
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
JP6755640B2
(ja)
|
2014-03-28 |
2020-09-16 |
味の素株式会社 |
甘味受容体キメラタンパク質及びその利用
|
EP3154585B1
(en)
|
2014-06-11 |
2022-02-23 |
Kathy A. Green |
Use of vista agonists and antagonists to suppress or enhance humoral immunity
|
AU2015357463B2
(en)
|
2014-12-05 |
2021-10-07 |
Immunext, Inc. |
Identification of VSIG8 as the putative vista receptor and its use thereof to produce vista/VSIG8 modulators
|
CN107922497B
(zh)
|
2015-06-24 |
2022-04-12 |
詹森药业有限公司 |
抗vista抗体和片段
|
TWI756204B
(zh)
|
2016-02-12 |
2022-03-01 |
比利時商楊森製藥公司 |
抗vista抗體及片段、其用途及鑑定其之方法
|
CN118108843A
(zh)
|
2016-04-15 |
2024-05-31 |
伊穆奈克斯特股份有限公司 |
抗人vista抗体及其用途
|
WO2019006246A1
(en)
*
|
2017-06-30 |
2019-01-03 |
The Rockefeller University |
N-ACYL AMIDES DERIVED FROM THE HUMAN MICROBIOTE FOR THE TREATMENT OF A HUMAN DISEASE
|
WO2021150686A1
(en)
|
2020-01-22 |
2021-07-29 |
Firmenich Incorporated |
High-sensitivity detection of gpcr activity and uses thereof
|